Tryptanthrin from Yinhuang Gargle Emerges as Anti-Inflammatory Candidate Against Periodontitis

Periodontitis, a chronic inflammatory disease driven by microbial biofilm dysbiosis and aberrant host immune responses, progressively destroys the alveolar bone that supports the teeth. A new study published in BMC Complementary Medicine and Therapies reports that Tryptanthrin, a bioactive constituent of Yinhuang Gargle, a hospital’s empirical traditional Chinese medicine formula, shows anti-inflammatory activity in laboratory cell experiments and emerges as a promising candidate for treating the disease.

Yinhuang Gargle is composed of six herbal ingredients: Scutellariae Radix (10 g), Phellodendri Chinensis Cortex (10 g), Lonicerae Japonicae Flos (5 g), Isatidis Folium (8 g), Agrimonia Eupatoria (5 g), and licorice (3 g). The research team set out to investigate the anti-inflammatory potential of one of its candidate active constituents using a multi-stage approach that combined computational prediction with laboratory validation.

The methods followed a defined sequence. Pharmacological databases were first used to screen the active components of the formula. Predicted action targets were then intersected with targets drawn from periodontitis-related disease databases, and a protein-protein interaction network was constructed to identify core targets. Gene Ontology and KEGG pathway enrichment analyses were performed on the resulting target sets, and molecular docking together with molecular dynamics simulation was employed to verify the interactions between key active compounds and the core targets.

The network pharmacology analysis indicated that the formula likely exerts its effects by modulating key targets including TNF-α, AKT1, BCL2, IL-6, and NFKB1. Inflammatory signaling pathways, including the TNF-α/NF-κB network, were identified as core pathways in the analysis.

Structural modelling provided further support for these predicted interactions. Molecular docking confirmed strong binding affinity between the bioactive compounds and the core targets.

The most direct evidence came from in vitro cell experiments. In these laboratory tests, Tryptanthrin reduced the expression of the pro-inflammatory cytokines IL-1β, IL-6, and TNF-α. The compound also downregulated the LPS-induced upregulation of iNOS and COX-2 at the protein level, further supporting its anti-inflammatory mechanism.

The authors conclude that the study identifies Tryptanthrin as a promising anti-inflammatory candidate for periodontitis and offers a valuable paradigm for mechanism-based discovery of bioactive constituents from traditional Chinese medicine formulas through the integration of network pharmacology, molecular docking, and in vitro experiments. The work illustrates how computational target prediction can be paired with structural verification and cell-based assays to narrow down which constituents of a multi-herb formula merit closer investigation.

Several limitations should be kept in view when interpreting these findings. The in vitro experiments validate effects in cells, not in patients, and the study’s conclusions rest on predicted targets and pathways rather than demonstrated clinical outcomes. The authors themselves describe Tryptanthrin as a candidate, and the computational analyses indicate likely mechanisms rather than proven therapeutic effects. As the article is an early-shared, peer-reviewed accepted version that remains subject to further edits before the final Version of Record, the findings should be read as an early-stage contribution to drug discovery for periodontitis rather than evidence of a validated treatment.

Within those boundaries, the study adds a concrete data point to ongoing efforts to find multi-target anti-inflammatory strategies for a disease that affects the tissues supporting the teeth. By pinpointing TNF-α, AKT1, BCL2, IL-6, and NFKB1 as core targets and documenting reduced cytokine and inflammatory protein expression in cells, the research provides a defined mechanistic framework that future studies can test in more complex biological systems.

Subject of Research: Network pharmacology and in vitro analysis of Tryptanthrin from Yinhuang Gargle as a candidate treatment for periodontitis

Article Title: Investigating the mechanism of Tryptanthrin, a bioactive constituent of Yinhuang Gargle, in treating periodontitis based on network pharmacology, molecular docking, molecular dynamics simulation and in vitro experiments

Article References: Wan, Y., Dong, F., Ren, Y., He, M., & Wang, W. (2026). Investigating the mechanism of Tryptanthrin, a bioactive constituent of Yinhuang Gargle, in treating periodontitis based on network pharmacology, molecular docking, molecular dynamics simulation and in vitro experiments. BMC Complementary Medicine and Therapies. https://doi.org/10.1186/s12906-026-05653-3

Image Credits: AI Generated

DOI: 10.1186/s12906-026-05653-3

Keywords: Tryptanthrin, Yinhuang Gargle, periodontitis, network pharmacology, molecular docking, molecular dynamics, traditional Chinese medicine, inflammation, NF-kB signaling, in vitro experiments, Investigating, mechanism